Perry A Karsen's Net Worth

$33.9 Million

Who is Perry A Karsen?

Perry A Karsen has an estimated net worth of $33.9 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, Jounce Therapeutics, Inc., Graphite Bio, Inc., Intellia Therapeutics, Inc., Voyager Therapeutics, Inc., NAVIDEA BIOPHARMACEUTICALS, INC., Alliqua, Inc., Jiya Acquisition Corp., CELGENE CORP /DE/, HUMAN GENOME SCIENCES INC, OncoMed Pharmaceuticals Inc, Stalar 3 Inc., and Stalar 4, Inc..

SEC CIK

Perry A Karsen's CIK is 0001260573

Past Insider Trading and Trends

2015 was Perry A Karsen's most active year for acquiring shares with 15 total transactions. Perry A Karsen's most active month to acquire stocks was the month of May. 2015 was Perry A Karsen's most active year for disposing of shares, totalling 15 transactions. Perry A Karsen's most active month to dispose stocks was the month of April. 2013 saw Perry A Karsen paying a total of $5,312,409.50 for 196,025 shares, this is the most they've acquired in one year. In 2013 Perry A Karsen cashed out on 298,145 shares for a total of $22,426,159.88, their largest year based on trade value.